SPONSOR
NovoCure GmbH
Total Trials
2
Recruiting
2
Phases
Phase 3
NCT06216301 Phase 3
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non-small Cell Lung Cancer
NCT06556563 Phase 3
Recruiting
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma